Sign in

NCT05722275Recruiting

Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics

Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics: a Multi-center Prospective Study

Source: ClinicalTrials.gov · Last updated 14 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Peritoneal metastasis of gastric cancer is difficult to be detected in time, thus delaying treatment. Based on the conventional CT images of gastric cancer, this study plans to develop, improve and validate an intelligent analysis system based on radiomics. By extracting and combining the radiomics features related to peritoneal metastasis of gastric cancer, the intelligent analysis system could predict the risk of peritoneal metastasis, and provide personalized decision suggestions for the treatment of gastric cancer.

Status (registry)
Recruiting
Study type
Observational
Enrollment
400 (estimated)
First submitted
30 Dec 2022
Start date
1 Jan 2023
Primary completion date
31 Dec 2023
Lead sponsor
Chinese Academy of Sciences
NCT number
NCT05722275

What you commit to

  • Study type: Observational
  • Planned participants: 400
  • From 1 Jan 2023 to the primary completion date, 31 Dec 2023
  • 13 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • (1) previous abdominal surgery;
  • (2) previous abdominal malignancies or inflammatory diseases;

Other

  • (3) time intervals between CT and laparoscopy longer than 2 weeks;
  • (4) CT image artifacts that undermine peritoneal lesion assessment.

Who the study is looking for

  • (1) diagnosed advanced gastric cancer (≥cT3) by endoscopy-biopsy pathology, combined with CT and/or endoscopic ultrasound;
  • (2) with both enhanced CT and laparoscopy;
  • (3) without typical peritoneal metastasis indications in CT (diffuse omental nodules or omental cake, large amount of ascites, obvious irregular thickening with high peritoneal enhancement);
  • (4) without other evidence of distant metastasis, and no stage IV features on CT.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Peking University Cancer Hospital & Institute
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Fujian Medical University Union Hospital
Coordinator of this site? Confirm its status
FuzhouChinaRecruiting
Guangdong Provincial People's Hospital
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting
Nanfang Hospital of Southern Medical University
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting
Sun Yat-sen University Cancer Hospital
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting
Guizhou Provincial People's Hospital
Coordinator of this site? Confirm its status
GuiyangChinaRecruiting
Yunnan Cancer Hospital
Coordinator of this site? Confirm its status
KunmingChinaRecruiting
Shanxi Province Cancer Hospital
Coordinator of this site? Confirm its status
TaiyuanChinaRecruiting
Henan Cancer Hospital
Coordinator of this site? Confirm its status
ZhengzhouChinaRecruiting
The First Affiliated Hospital of Zhengzhou University
Coordinator of this site? Confirm its status
ZhengzhouChinaRecruiting
Zhenjiang First People's Hospital
Coordinator of this site? Confirm its status
ZhenjiangChinaRecruiting
Scientific Institute San Raffaele
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.